pharmaceutical industry

Pharma bribery corrupts health care, puts patients at risk, new review warns

Kickbacks, sham studies and regulatory payoffs distort prescribing and drug approvals

|
Print Email Share Tweet LinkedIn WhatsApp Reddit Telegram
Pills and 100 dollar bills

Sham clinical studies, slush funds, luxury gifts, and shell companies: A new review shows how pharma firms allegedly bribed their way to drug approvals and sales.

Billions in drug and medical device company payments to medical specialists may compromise patient care, reports show

|
Print Email Share Tweet LinkedIn WhatsApp Reddit Telegram
A physician holding out some pills

U.S. medical specialists – from neurosurgeons to anesthesiologists and oncologists – received billions of dollars worth of individual payments not related to research from pharmaceutical and medical device industries in recent years, new research shows.